Petrelintide, an amylin agonist medication, may support weight loss with fewer gastrointestinal side effects than GLP-1 drugs, according to early research.
Background The role of intrinsic tumour heterogeneity in driving organ-tropic metastasis in gastric cancer remains ...
Alimentiv and International Bowel Ultrasound Group Expand Partnership to Include Ultrasound Training for Clinical TrialsPartnership launches IUS-STAR, a structured training and certification program f ...
Most patients (21 of 26; 80.8%) had TRAEs of Grade 2 or lower, consistent with MEK1/2 inhibition, including dermatitis acneiform, rash, CPK increase, diarrhea, and asymptomatic LVEF decrease. Grade 3 ...
Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...
STAR, a structured training and certification program for clinical trial imaging professionals. LONDON, ON and BERLIN, Oct.
Featured science includes endurance running and ischemic colitis, AI recognition of emergencies in different languages, sleep quality vs. sleep duration and MASLD risk, and assisted reproductive techn ...
ACG is addressing AI- and workforce-driven shifts in gastroenterology with investment in biomedical innovation and modernized education initiatives, the outgoing president said at ACG Annual ...
Introduction Depressive disorders are a major cause of disability worldwide and are frequently accompanied by somatic ...
Iterative Health, a health care technology and services company in Cambridge, Mass., powering the acceleration of clinical research, announced July 9 a strategic partnership with Clifton-based ...
This collaboration aligns with the trend of decentralizing clinical research into community healthcare networks, enhancing patient access to cutting-edge therapies. Iterative Health’s growing network ...
CAMBRIDGE, Mass., July 08, 2026--(BUSINESS WIRE)--Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced a strategic partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results